We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Untitled Letter Warns Valisure About Pharmacy-Related Lapses
Untitled Letter Warns Valisure About Pharmacy-Related Lapses
The FDA rapped independent testing lab Valisure in an untitled letter for violating the Drug Supply Chain Security Act (DSCSA) and for “methodological deficiencies” in its testing protocols, disputing the company’s claims that its pharmacy business was not subject to FDA regulation.